Thomas P Morrissey MD FACOG, FACS
Gynecologic Oncology
Director of Gynecologic Oncology, Lynn Cancer Institute-Baptist Health South Florida
Baptist Health Lynn Cancer Institute701 NW 13th StBoca Raton, FL 33486
Fax+1 833-625-1600
Overview of Dr. Morrissey
Dr. Thomas Morrissey is a Gynecologic Oncologist in Boca Raton, FL and is affiliated with Lynn Cancer Institute/Baptist Health South Florida. He received his undergraduate degree from Columbia University, medical degree from State University of New York Upstate Medical University, OBGYN Residency at the University of Pittsburgh/Magee-Womens Hospital and Fellowship in Gynecologic Oncology at the University of North Carolina-Chapel Hill and has been in practice 22 years. He also speaks multiple languages, including Spanish. He specializes in gynecologic oncology and is dedicated to the surgical and chemotherapeutic treatment of all gynecologic malignancies including ovarian cancer, uterine cancer, cervical cancer, vulvar cancer, precancerous conditions of the vulva/vagina/cervix including management of abnormal pap smears, gynecologic care of patients with breast cancer, and care of patients with genetic mutations placing them at high risk for development of cancer. Dr. Morrissey also has extensive experience in robotic assisted laparoscopic surgery for cancer and complex benign conditions.
Education & Training
University of North Carolina HospitalsFellowship, Gynecologic Oncology, 1999 - 2002
UPMC Medical EducationResidency, Obstetrics and Gynecology, 1995 - 1999
SUNY Upstate Medical UniversityClass of 1995
Certifications & Licensure
FL State Medical License 2014 - 2028
NY State Medical License 2002 - 2015
NC State Medical License 1999 - 2003
PA State Medical License 1996 - 2000
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MEDENT, Community Computer Service, Inc., 2013, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2016-2017
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Press Mentions
What You Need to Know About Gynecological CancersJune 22nd, 2016
Professional Memberships
- Fellow
- Member
- Society of Gynecologic OncologistsMember
Other Languages
- Spanish
Insurance Accepted
- Aetna Choice POS II
BCBS Blue Card PPO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPOGreat West PPO
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: